期刊文献+

Clinical significance of expression of tissue factor and tissue factor pathway inhibitor in ulcerative colitis 被引量:4

Clinical significance of expression of tissue factor and tissue factor pathway inhibitor in ulcerative colitis
下载PDF
导出
摘要 AIM: To investigate the clinical significance of expression of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in ulcerative colitis (UC). AIM:To investigate the clinical significance of expression of tissue factor(TF)and tissue factor pathway inhibitor(TFPI)in ulcerative colitis(UC).METHODS:Thirty UC specimens taken by colonoscopy from patients with active UC treated at the Department of Pathology,Central Hospital Affiliated to Shenyang Medical College from February 2010 to January 2012were included in an experimental group,and 30 normal colon tissue samples taken by colonoscopy from nonUC patients were included in a control group.Expression of TF and TFPI in UC and normal colon tissue samples was detected by immunohistochemistry.RESULTS:The positive rate of TF in UC was significantly higher than that in normal colon tissue(63%vs33%,χ2=5.41,P<0.05).The positive rate of TFPI in UC was also significantly higher than that in normal colon tissue(43%vs 17%,χ2=5.08,P<0.05).CONCLUSION:Positive rates of TF and TFPI expression in UC are significantly higher than those in normal colon tissue.TF and TFPI may play an important role in the pathogenesis of UC.
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第23期7461-7465,共5页 世界胃肠病学杂志(英文版)
关键词 Ulcerative colitis Tissue factor Tissue factor pathway inhibitor Ulcerative colitis Tissue factor Tissue factor pat
  • 相关文献

参考文献8

二级参考文献39

  • 1赵明,包承鑫.组织因子途径抑制物的研究进展[J].中华血液学杂志,1995,16(9):495-497. 被引量:9
  • 2Glahn J. Genetic variations in the human TFPI-2 gene and its promoter region by denaturing high performance liquid chmmatogrphy [ J ]. Thremb Res,2004,113 (2) :341-343.
  • 3Hube F, Reverdiau P, Ioehmann S,et al. Computer model of the interaction of human TFPI-2 Kunitz type sefine protease inhibitor with human plasmin [ J ]. Thromb Res ,2003,111 ( 1 ) : 197-198.
  • 4Chand HS, Schmidt AE, Bajaj SP, et al. Structure-function analysis of the reactive site in the first kunitz-type domain oihuman tissue factor pathway inhibitor-2 [ J ]. J Bid Chem, 2004, 279 ( 17 ) : 17500-17507.
  • 5Liu YY,Stack SM,Lakka SS,et al. Matrix loeallotion of tissue factorpathway inhibitor-2/matrix) associated serine protease inhibitor (TFPI-2/MSPI) involves Arglnine mediated ionie interactions with heparin and dermatan sulfate: Heparin aceelerates the activity of TFPI-2/MSPI toward plasmin [ J ]. Arch Bioehem Biophys, 1999, 370( 1 ) :112-118.
  • 6Hub6 F, Reverdiau P, Iochmann S,et al. Characterization and funetional analysis of TFPI-2 gene promoter in a human chorioearcinomaeell line[J]. Thromb Res,2003,109(2) :207-215.
  • 7Esteller M. Aberrant DNA mcthylation as a cancer inducing mechanism [ J ]. Annu Rev Pharmacol Toxicol, 2005,45 (4) : 629 -656.
  • 8Miyagi Y, Koshikawa N, Yasumtisu H, et al. Cdna and Mrna expression of a serine proteinase secreted by cancer cells : indentification as plas protein 5 and tissue factor pathwayinhibitor-2 [ J ]. Biochem, 1994,116 (4) :939-942.
  • 9Sell SM, Tullis C, Stracner D, et al. Minimal interval defined on 7q inuter-ineleiomyoma [ J ]. Cancer Genet Cytogenet, 2005,157 ( 1 ) : 67 -69.
  • 10Sato N, Parker AR, Fukushima N, et al. Epigenetic inactivatin of TFPI-2 as a common mechanism associted with growth and invasion of pancreatic ductal adenocarcinoma [ J ]. Oncogene ,2005,24 ( 4 ) : 850-858.

共引文献86

同被引文献57

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部